| Active Biotech to Present at the Jefferies 2011 Global Healthcare Conference - Reuters (press release) |
|
|
Reuters (press release) Projects in pivotal phase are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, TASQ for prostate cancer and ANYARA for use in cancer targeted therapy, primarily of renal |